MicroRNA-128-2 targets the transcriptional repressor E2F5 enhancing mutant p53 gain of function-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

MicroRNA-128-2 targets the transcriptional repressor E2F5 enhancing mutant p53 gain of function

Published:2011-12-23 Issue:6 Volume:19 Page:1038-1048
ISSN:1350-9047
Container-title:Cell Death & Differentiation
language:en
Short-container-title:Cell Death Differ

Author:

Donzelli S,Fontemaggi G,Fazi F,Di Agostino S,Padula F,Biagioni F,Muti P,Strano S,Blandino G

Publisher

Springer Science and Business Media LLC

Subject

Cell Biology,Molecular Biology

Link

http://www.nature.com/articles/cdd2011190.pdf

Reference43 articles.

1. Hollstein M, Sidransky D, Vogelstein B, Harris CC . p53 mutations in human cancers. Science 1991; 253: 49–53.

2. Hainaut P, Hollstein H . p53 and human cancer: the first ten thousand mutations. Adv Cancer Res 2000; 77: 81–137.

3. Ory K, Legros Y, Auguin C, Soussi T . Analysis of the most representative tumour-derived p53 mutants reveals that changes in protein conformation are not correlated with loss of transactivation or inhibition of cell proliferation. EMBO J 1994; 13: 3496–3504.

4. Bullock AN, Fersht AR . Rescuing the function of mutant p53. Nat Rev Cancer 2001; 1: 68–76.

5. Dittmer D, Pati S, Zambetti G, Chu S, Teresky AK, Moore M et al. Gain of function mutations in p53. Nat Genet 1993; 4: 42–46.

Cited by 135 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Modulatory effects of miRNAs in doxorubicin resistance: A mechanistic view;Functional & Integrative Genomics;2024-09-02

2. Exploring the versatility of miRNA-128: a comprehensive review on its role as a biomarker and therapeutic target in clinical pathways;Molecular Biology Reports;2024-07-28

3. Post-Translational Modifications (PTMs) of mutp53 and Epigenetic Changes Induced by mutp53;Biology;2024-07-08

4. An engineered DNA aptamer-based PROTAC for precise therapy of p53-R175H hotspot mutant-driven cancer;Science Bulletin;2024-07

5. Cell fate regulation governed by p53: Friends or reversible foes in cancer therapy;Cancer Communications;2024-02-04

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3